ArticleFrontiers in cardiovascular medicine2025
Global burden of hypertensive heart disease attributable to high body mass index from 1990 to 2021: a multidimensional analysis and public health response.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global, regional, and national trends in hypertensive heart disease burden due to high BMI: a 30-year analysis using GBD 2021 data with projections to 2035.Frontiers in public health · 2026Article
- Analysis of temporal and spatial changes in the global burden of hypertensive heart disease based on data from the Global Burden of Disease study database and future projections: 1990-2046.Frontiers in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the global population of obese individuals surpasses 878 million, the impact of high body mass index (BMI) on hypertensive heart disease (HHD) has risen to the third position among all diseases. However, the specific contribution of high BMI to the burden of HHD remains unclear. Methods: Data on deaths, disability-adjusted life years (DALYs), and their age-standardized rates (ASR) were obtained from the Global Burden of Disease (GBD) database. Population attributable fractions (PAF) was used to assess the contribution of risk factors. Various analytical methods, including decomposition analysis, cluster analysis, frontier analysis, age-period-cohort (APC) analysis, and Bayesian age-period-cohort (BAPC) analysis, were employed to investigate changes in disease burden. Results: The results showed an increasing global burden of HHD due to high BMI, with both mortality and DALYs doubling over the past 30 years. Their ASR also continued to rise. By 2021, the PAF for deaths and DALYs reached 44% and 49%, respectively. Population growth and aging were significant contributors to this disease burden. Low- and middle- Socio-Demographic Index (SDI) regions experienced the highest burden, particularly in East Asia, South Asia, North Africa and Middle East. Although the disease burden was lower in high-income areas, the increase was notable, especially in North America. Women and older populations faced higher risks, particularly alarming is the rapid increase in risk among younger populations in high SDI regions. Conclusion: HHD resulting from high BMI poses a significant global public health challenge, particularly in regions with middle and low SDI. While the heightened risk among women and older individuals has garnered considerable attention, the increasing risk among younger populations also necessitates greater focus. Targeted interventions should prioritize diet, exercise, medical security, and health education, with particular emphasis on enhancing policy support for low-income and high-risk groups. Future policies must integrate the social, economic, and cultural contexts of each region, implement comprehensive prevention and control strategies, and establish a multi-dimensional health promotion system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.